PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation

PF573,228 is a compound that targets focal adhesion kinase (FAK), a non-receptor protein kinase, which is over-expressed in various tumors. The aim of this study was to evaluate the effects of PF573,228 on the cells derived from mouse vascular tumors, namely, endothelioma cells.

Saved in:
Bibliographic Details
Main Author: Mabeta Peace
Format: Article
Language:English
Published: Sciendo 2016-09-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.1515/acph-2016-0031
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572102995083264
author Mabeta Peace
author_facet Mabeta Peace
author_sort Mabeta Peace
collection DOAJ
description PF573,228 is a compound that targets focal adhesion kinase (FAK), a non-receptor protein kinase, which is over-expressed in various tumors. The aim of this study was to evaluate the effects of PF573,228 on the cells derived from mouse vascular tumors, namely, endothelioma cells.
format Article
id doaj-art-e17d04c4d5224207a0cf4135975e6d77
institution Kabale University
issn 1846-9558
language English
publishDate 2016-09-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-e17d04c4d5224207a0cf4135975e6d772025-02-02T11:59:26ZengSciendoActa Pharmaceutica1846-95582016-09-0166339941010.1515/acph-2016-0031acph-2016-0031PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylationMabeta Peace0Angiogenesis Laboratory Department of Anatomy and Physiology University of Pretoria, Private Bag X04 Tshwane, 0110, South AfricaPF573,228 is a compound that targets focal adhesion kinase (FAK), a non-receptor protein kinase, which is over-expressed in various tumors. The aim of this study was to evaluate the effects of PF573,228 on the cells derived from mouse vascular tumors, namely, endothelioma cells.https://doi.org/10.1515/acph-2016-0031pf573,228focal adhesion kinaseendotheliomaapoptosisangiogenesis
spellingShingle Mabeta Peace
PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation
Acta Pharmaceutica
pf573,228
focal adhesion kinase
endothelioma
apoptosis
angiogenesis
title PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation
title_full PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation
title_fullStr PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation
title_full_unstemmed PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation
title_short PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation
title_sort pf573 228 inhibits vascular tumor cell growth migration as well as angiogenesis induces apoptosis and abrogates pras40 and s6rp phosphorylation
topic pf573,228
focal adhesion kinase
endothelioma
apoptosis
angiogenesis
url https://doi.org/10.1515/acph-2016-0031
work_keys_str_mv AT mabetapeace pf573228inhibitsvasculartumorcellgrowthmigrationaswellasangiogenesisinducesapoptosisandabrogatespras40ands6rpphosphorylation